Yunfei Zhi

Yunfei Zhi

Auto-generated profile, based on publicly available information

Yunfei Zhi

Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2021 in Oncogenesis
Verified
Journal Article
Open access
PDF file
QLQing Liao
Qing Liao
YRYun Ren
Yun Ren
YYYuyi Yang
Yuyi Yang
XZXiaohui Zhu
Xiaohui Zhu
YZYunfei Zhi
Yunfei Zhi
LZLiang Zhao
Liang Zhao
LIM and SH3 protein 1 (LASP1) is a metastasis-related protein reported to enhance tumor progression in colorectal cancer (CRC). However, the underlying mechanism is still elusive. The chaperonin protein containing TCP1 (CCT) is a cellular molecular chaperone complex, which is necessary for the correct folding of many proteins. It contains eight subunits, CCT1-8. CCT8 is overexpressed in many cancers, however, studies on CCT8 are limited and its role on CRC development and progression remains elusive. In this study, we confirmed that CCT8 and LASP1 can interact with each other and express positively in CRC cells. CCT8 could recover the ability of LASP1 to promote the invasion of CRC; CCT8 could significantly promote the proliferation, invasion, and metastasis of colorectal cells in vivo and in vitro. Mechanically, CCT8 inhibited the entry of WTp53 into the nucleus, and there was a negative correlation between the expression of CCT8 and the nuclear expression of WTp53 in clinical colorectal tissues. CCT8 promoted the cell cycle evolution and EMT progression of CRC by inhibiting the entry of WTp53 into the nucleus. Clinically, CCT8 was highly expressed in CRC. More importantly, the overall survival of CRC patients with high expression of CCT8 was worse than that of patients with low expression of CCT8. These findings indicate that as LASP1-modulated proteins, CCT8 plays a key role in promoting the progression of colorectal cancer, which provides a potential target for clinical intervention in patients with colorectal cancer.

8 March 2021 in Oncogene
Verified
Journal Article
Closed access
PDF file
ZPZhihua Pan
Zhihua Pan
CLChaoqun Liu
Chaoqun Liu
YZYunfei Zhi
Yunfei Zhi
ZXZhiyue Xie
Zhiyue Xie
LWLing Wu
Ling Wu
LZLiang Zhao
Liang Zhao

10 August 2026 in Nature Communications
Verified
Journal Article
Open access
YLYuhan Liao
Yuhan Liao
XCXinhua Chen
Xinhua Chen
HCHaiyun Chen
Haiyun Chen
LXLunbo Xie
Lunbo Xie
YZYunfei Zhi
Yunfei Zhi
LZLiang Zhao
Liang Zhao
Human epidermal growth factor receptor 2 (HER2) expression is a distinctive feature of a subgroup of gastric cancer (GC) but the underpinning characteristics of the immune microenvironment and mechanisms remain unclear. In the study, spatial transcriptomics and single-cell RNA sequencing are used on treatment-naïve HER2-positive and HER2-negative GC specimens to characterize the tumor microenvironment and spatial architecture with the aim of defining how HER2 status shapes the tumor immune microenvironment (TIME) and its cellular interactions. We find that C1Q⁺ macrophages spatially and functionally interact with CD8⁺ T cells via Galectin-9 (LGALS9), which is downregulated in HER2-positive tumors. Knocking down LGALS9 enhancesCD8⁺ T cell function and suppresses tumor growth in a CD8⁺ T cell-dependent manner, further amplified by anti-PD-1 treatment. Conversely, SFRP2⁺ cancer-associated fibroblasts (CAF) promote CD8⁺ T cell exhaustion through CXCL12-CXCR4 signaling, and knocking down CXCL12 reverses this immunosuppressive effect. HER2-positive tumors are characterized by an immune-favorable niche enriched in C1Q⁺ macrophages and CD8⁺ T effector memory cells but a decrease in SFRP2⁺ CAFs, suggesting its potential as a predictive biomarker for response to combined anti-PD-1 and anti-HER2 therapies. These findings provide insight into the spatial and immune landscape of HER2-associated GC and may inform future precision treatment strategies.

1 January 2020 in Technology in Cancer Research & Treatment
Verified
Journal Article
Open access
PDF file
YZYunfei Zhi
Yunfei Zhi
ZLZhousheng Lin
Zhousheng Lin
JMJinyuan Ma
Jinyuan Ma
WMWeiming Mou
Weiming Mou
XCXinhua Chen
Xinhua Chen
Background: Although the landmark INT-0116 trial and National Comprehensive Cancer Network (NCCN) guidelines recommended pT3-4Nx gastric cancer (GC) patients to receive chemoradiotherapy, the role of radiotherapy has not been distinguished from chemoradiotherapy. Methods: GC with behavior of metastasis-indolent in lymph node (MILN) being confirmed with more than 15 examined LNs after gastrectomy were identified using the Surveillance, Epidemiology and End Result (SEER) database. The cancer-specific survival (CSS) of subgroups for radiotherapy, chemotherapy, chemoradiotherapy and non-adjuvant-treatment were compared. Propensity score matching (PSM) was performed between radiotherapy and non-radiotherapy subgroups to further distinguish the role of radiotherapy from chemoradiotherapy. Cox regression was performed to identify whether radiotherapy or chemotherapy could independently improve prognosis. Results: We identified 690 MILN GC patients in SEER database. 5-year CSS was 71.9% in radiotherapy subgroup and 75.1% in non-radiotherapy subgroup(HR = 1.013, 95% CI = 0.714-1.438, p = 0.940), 75.6% in chemotherapy subgroup and 68.5% in non-chemotherapy subgroup(HR = 0.616, 95% CI = 0.430-0.884, p = 0.008), 52.5% in radiotherapy-alone subgroup and 71.9% in non-adjuvant treatment group (HR = 1.604, 95% CI = 0.575-4.471, p = 0.360), 72.9% in chemoradiotherapy subgroup and 79.5% in chemotherapy-alone subgroup (HR = 1.365, 95% CI = 0.859-2.172, p = 0.185), respectively. Further, PSM markedly improved balance of variables between radiotherapy subgroup and non-radiotherapy subgroup. After PSM, the role of the variables of radiotherapy and chemotherapy in contributing to improving CSS are consistent with that before PSM. Cox regression showed chemotherapy, tumor size, tumor invasiveness and Lauren classification were independent prognostic factors, but not including radiotherapy. Conclusions: Chemoradiotherapy confers superior prognosis to MILN GC patients compared with surgery alone might only be attributed to chemotherapy rather than radiotherapy.